Focused on targeted treatments for rare diseases
| Website | http://www.nflectionrx.com |
| Employees | 10 (2 on RocketReach) |
| Founded | 2014 |
| Phone | +1 617-546-7606 |
| Industry | Biotechnology, Research, Science and Engineering, Therapeutics, Health Care |
| Keywords | Rare Disease Research, Therapeutic Solutions, Rare Disease Therapeutics, Novel Therapies, Targeted Treatments, Innovative Treatments, Orphan Drug Development, Personalized Medicine, Precision Medicine, Advanced Therapies, Genetic Disorders, Drug Development, Drug Discovery, Clinical Research, Medical Research, Clinical Trials, Biopharma, Pharmaceutical Research, Health Solutions, Biotechnology |
| Competitors | Albireo Pharma, Inc., HOOKIPA Pharma Inc., Evoke Pharma, CureVac, Silence Therapeutics plc, Dynavax Technologies, Viela Bio, Galecto, Inc., Akcea Therapeutics, AstraZeneca +39 more (view full list) |
Looking for a particular NFlection Therapeutics, Inc. employee's phone or email?
NFlection Therapeutics, Inc. Questions
William Hodder is the CEO of NFlection Therapeutics, Inc..
2 people are employed at NFlection Therapeutics, Inc..
NFlection Therapeutics, Inc. is based in Boston, Massachusetts.
Top NFlection Therapeutics, Inc. Employees
-
William Hodder
Chief Executive Officer at NFlection Therapeutics, Inc.
California, United States25+
Related Companies
G2Crowd Trusted
300K+
Plugin Users
